/NXGB
NXGB Stock - NxGen Brands Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+62.50%
+$0.00 (+62.50%) • Dec 19
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.40
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NXGB
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.00
52W High$0.10
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $27,439 | $37,589 | $15,133 | $40,419 | $230,073 |
| Gross Profit | $19,491 | $-43,949 | $15,133 | $20,586 | $90,541 |
| Gross Margin | 71.0% | -116.9% | 100.0% | 50.9% | 39.4% |
| Operating Income | $-106,000 | $-209,000 | $700 | $-198,000 | $-158,000 |
| Net Income | $-135,000 | $-417,000 | $-48,533 | $-247,000 | $-202,000 |
| Net Margin | -492.0% | -1109.4% | -320.7% | -611.1% | -87.8% |
| EPS | $-0.00 | $-0.01 | $-0.00 | $-0.01 | $-0.01 |
Company Overview
NxGen Brands Inc., doing business as, LeafyWell, engages in manufacturing, distributing, and marketing various cannabidiol (CBD) supplements. It focuses on offering CBD and hemp derived gummies, oils, vape liquids, pet treats, and other products. The company is based in Davie, Florida.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NXGBLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about NXGB
What is NXGB's current stock price?
NxGen Brands Inc. (NXGB) is currently trading at $0.00 per share. The stock has moved +62.50% today.
What is the analyst price target for NXGB?
No analyst price targets are currently available for this stock.
What sector is NxGen Brands Inc. in?
NxGen Brands Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is NXGB's market cap?
NxGen Brands Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does NXGB pay dividends?
No, NxGen Brands Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBZAMF
BZAM Ltd.
$0.00
Mkt Cap: $0.0B
CANQF
CanaQuest Medical Corp.
$0.00
Mkt Cap: $0.0B
COTQF
Cotinga Pharmaceuticals Inc.
$0.00
Mkt Cap: $0.0B
ETAOF
ETAO International Co., Ltd.
$0.00
Mkt Cap: $0.0B
FORU
ForU Holdings, Inc.
$0.00
Mkt Cap: $0.0B
GENX
Genex Pharmaceutical, Inc.
$0.00
Mkt Cap: $0.0B
RSCI
Redwood Scientific Technologies, Inc.
$0.01
Mkt Cap: $0.0B
SYUP
Anbc, Inc.
$0.00
Mkt Cap: $0.0B
TBET
Tibet Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
ULGX
Urologix, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to NXGB for comparison